Glaukos Corporation
GKOS
Classificação em ações
#2026
Glaukos Corporation operates as an ophthalmic medical technology and... Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.
Preço da ação
$174.03
Última sincronização: 2026-10-20
Valor de mercado
$10.26B
Variação (1 dia)
4.34%
Variação (1 ano)
129.35%
País
US
Negociar Glaukos Corporation (GKOS)
Categoria
Healthcare
Receita da Glaukos Corporation (GKOS)
Receita em Jun 2026 TTM: $612.84M
De acordo com os últimos relatórios financeiros da Glaukos Corporation, a receita atual da empresa (TTM) é $612.84M. Em 2023, a empresa obteve uma receita de $314.71M um aumento em relação a a receita do ano 2022, que foi de $282.86M. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Glaukos Corporation de 2012 a 2026
Receita no final de cada ano
| Ano | Receita | Alterar |
|---|---|---|
| 2026 (TTM) | $612.84M | 59.81% |
| 2024 | $383.48M | 21.85% |
| 2023 | $314.71M | 11.26% |
| 2022 | $282.86M | -3.79% |
| 2021 | $294.01M | 30.70% |
| 2020 | $224.96M | -5.07% |
| 2019 | $236.98M | 30.73% |
| 2018 | $181.28M | 13.83% |
| 2017 | $159.25M | 39.21% |
| 2016 | $114.40M | 59.55% |
| 2015 | $71.70M | 57.28% |
| 2014 | $45.59M | 117.64% |
| 2013 | $20.95M | 762.33% |
| 2012 | $2.43M | 0.00% |
Receita de empresas similares ou concorrentes
| Empresa | Receita | Diferença de Receita | País |
|---|---|---|---|
| $46.59B | 7,501.51% |
US
|
|
| $35.48B | 5,690.10% |
IE
|
|
| $25.84B | 4,115.95% |
US
|
|
| $21.00B | 3,326.02% |
US
|
|
| - | - |
DE
|
